Bioanalytical Community

The China Bioanalytical Support Discussion Group is conducting a survey with respect to experiences related to bioanalytical support for clinical studies conducted in China.  If your company does not have a representative to the China Bioanalytical Support Discussion group and is interested in participating in the survey, please message me.  Results will be shared with the discussion group and will form the basis of a presentation at a future AAPS meeting.  Responses should be limited to one per company per site.

The China Bioanalytical Support Discussion Group is conducting a survey with respect to experiences related to bioanalytical support for clinical studies conducted in China.  If your company does not have a representative to the China Bioanalytical Support Discussion group and is interested in participating in the survey, please message me.  Results will be shared with the discussion group and will form the basis of a presentation at a future AAPS meeting.  Responses should be limited to one per company per site.

The China Bioanalytical Support Discussion Group is conducting a survey with respect to experiences related to bioanalytical support for clinical studies conducted in China.  If your company does not have a representative to the China Bioanalytical Support Discussion group and is interested in participating in the survey, please message me.  Results will be shared with the discussion group and will form the basis of a presentation at a future AAPS meeting.  Responses should be limited to one per company per site.

The China Bioanalytical Support Discussion Group is conducting a survey with respect to experiences related to bioanalytical support for clinical studies conducted in China.  If your company does not have a representative to the China Bioanalytical Support Discussion group and is interested in participating in the survey, please message me.  Results will be shared with the discussion group and will form the basis of a presentation at a future AAPS meeting.  Responses should be limited to one per company per site.